Adipotide (FTPP) 10mg – Research Peptide for Fat Loss and Metabolic Health

Adipotide, also known as FTPP, is a groundbreaking research peptide currently being studied for its potential to selectively target and eliminate fat cells. It works by disrupting the blood supply that nourishes white adipose tissue, leading to fat cell death and, as studies suggest, significant weight reduction and metabolic benefits.

What Is Adipotide?

Adipotide is an experimental compound known as a proapoptotic peptide. It’s designed to recognize and attach to specific blood vessels that supply white fat tissue, ultimately causing those blood vessels—and the fat cells they support—to die off. What makes Adipotide especially fascinating is its precision: it leaves other blood vessels in the body untouched, targeting only those linked to fat deposits.

Originally developed to support weight management and metabolic health, Adipotide has also caught the attention of researchers exploring treatments for type 2 diabetes and certain forms of cancer.

How Adipotide Works

Adipotide induces apoptosis (programmed cell death) in the blood vessels of white adipose tissue. Without a steady blood supply, these fat cells cannot survive. This targeted mechanism has shown impressive results in animal studies, especially in obese rhesus monkeys:

• Rapid fat loss and reduction in body mass index (BMI)

• Improved insulin sensitivity

• Decreased appetite and food intake

Interestingly, these outcomes occurred even without corresponding weight loss in some cases, highlighting the compound’s ability to alter fat tissue composition and metabolic performance.

Research Highlights

Fat Loss & Body Composition

In clinical trials involving obese monkeys, Adipotide was shown to:

• Trigger direct fat cell death

• Reduce body weight and BMI

• Decrease food cravings and overall food intake

MRI scans and DEXA testing confirmed that Adipotide caused a significant drop in white fat levels.

Metabolic Benefits & Glucose Tolerance

One of Adipotide’s standout findings is its ability to improve glucose tolerance—a key marker for insulin resistance and type 2 diabetes. In some studies, these benefits occurred independently of weight loss, suggesting that the loss of fat tissue itself—not just weight—plays a role in improving metabolic health.

Cancer Research Potential

Adipotide interacts with a protein called prohibitin, which is present in blood vessels that supply fat cells and also in some cancer cells. Because of this, researchers are investigating its potential as a targeted therapy in oncology. If proven effective, Adipotide could represent a new class of treatments that affect only specific tissues while sparing healthy cells.

Peptide Details

• Sequence: Cys-Lys-Gly-Gly-Arg-Ala-Lys-Asp-Cys-Gly-Gly-(Lys-Leu-Ala-Lys-Leu-Ala-Lys)

• Molecular Weight: 2611.41 g/mol

Safety & Usage

Adipotide has demonstrated favorable outcomes in preclinical studies, particularly in mice and non-human primates. It has shown good subcutaneous absorption and minimal side effects in those settings. However, it’s important to note that Adipotide is not approved for human or veterinary use. It is intended strictly for scientific and in-vitro research purposes only.

For Research Use Only

All Amino Pharm products, including Adipotide (FTPP) 10mg, are intended solely for laboratory and educational use. They are not approved by the FDA and are not meant to diagnose, treat, cure, or prevent any disease. Use is strictly limited to qualified professionals and licensed researchers.